STTK Stock Analysis: Buy, Sell, or Hold?
STTK - Shattuck Labs, Inc. Common Stock
$6.25
-0.18 (-2.80%)
▼
5d:
-1.88%
30d:
+47.75%
90d:
+73.61%
BUY
MODERATE Confidence
Analysis Updated: Apr 1, 2026 12:00 AM ET
Earnings: May 07, 2026
Smart Money Accumulation
STTK is down 7.7% this week, but smart money is accumulating calls. Top strike: $5 2026-03-20 with 290 OI. Call ratio: 100% View Scanner →
Strength: 8.8/10
Get Alerted When STTK Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: STTK shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
💡 BUY OPPORTUNITY: STTK shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: STTK is currently trading at $6.25, which is considered slightly high relative to its 30-day fair value range of $4.64 to $6.40.
Technical Outlook: Technically, STTK is in a strong uptrend. Immediate support is located at $5.75, while resistance sits at $6.81.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $10.00 (+60.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, STTK is in a strong uptrend. Immediate support is located at $5.75, while resistance sits at $6.81.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $10.00 (+60.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Fair Price Range
$4.64 -
$6.40
Company Quality Score
60/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
73.8%
All Signals
- BULLISH: Options cheap (IV 0th percentile)
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 60.0% below Wall St target ($10.00)
Fair Price Analysis
30-Day Fair Range
$4.64 -
$6.40
Current vs Fair Value
SLIGHTLY HIGH
Expected Move (7 Days)
±$1.06
(17.0%)
Support & Resistance Levels
Support Level
$5.75
Resistance Level
$6.81
Current Trend
Strong Uptrend
Technical data as of
Apr 1, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-13.09
Wall Street Target
$10.00
(+60.0%)
Revenue Growth (YoY)
-66.6%
Share & Embed Analysis
Last updated: April 01, 2026 6:02 PM ET
Data refreshes hourly during market hours. Next update: 7:02 PM
Data refreshes hourly during market hours. Next update: 7:02 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is STTK showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$411 | 52 HOLD |
|
INSM
Insmed Inc |
STRONG BUY
19 analysts |
$213 | 66 BUY |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$111 | 57 HOLD |
|
RCKT
Rocket Pharmaceuticals I… |
STRONG BUY
18 analysts |
$8 | 52 HOLD |
|
IMVT
Immunovant Inc |
STRONG BUY
14 analysts |
$40 | 62 BUY |
